Cargando…

Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience

OBJECTIVE: Chemoport-related thrombosis (CRT) is a serious complication that causes morbidities and interrupts administration of intravenous cancer therapy. We investigated the incidence and risk of CRT in colorectal cancer (CRC) patients treated with bevacizumab (BEV). METHODS: We retrospectively r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jwa Hoon, Kim, Jeong Eun, Hong, Yong Sang, Kim, Sun Young, Kim, Kyu-pyo, Choi, Ki Eun, Shin, Ji Hoon, Kim, Tae Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129570/ https://www.ncbi.nlm.nih.gov/pubmed/30210226 http://dx.doi.org/10.21147/j.issn.1000-9604.2018.04.09

Ejemplares similares

Percutaneous Retrieval of an Embolized Central Venous Chemoport in a Patient With Colon Cancer
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
por: Bang, Yeong Hak, et al.
Publicado: (2021)

Bacteremia due to Rahnella aquatilis in a Patient with a Chemoport
por: Lee, Woo Joo, et al.
Publicado: (2019)

Modified Technique of Chemoport Placement in Severely Obese Patient for Administration of Chemotherapy
por: Cho, Sungbin, et al.
Publicado: (2023)

Totally Implantable Venous Access Device (Chemoport) in Oncology: Study of 168 Polyurethane Chemoport Catheter System
por: Mittal, Gyanendra Swaroop, et al.
Publicado: (2021)

Accidental arterial chemoport catheter insertion
por: Bihani, Pooja, et al.
Publicado: (2020)

Disc Dislocation of Chemoport: An Unseen Complication
por: Sushma, A., et al.
Publicado: (2023)

Fasting Blood Sugar and Serum Triglyceride as the Risk Factors of Colorectal Adenoma in Korean Population Receiving Screening Colonoscopy
por: Pyo, Jeung Hui, et al.
Publicado: (2013)

Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
por: Kim, Jwa Hoon, et al.
Publicado: (2018)

Role of Chemoports in Children with Hematological/Solid Tumor Malignancies - Technical Implications and Complications: An Institutional Experience
por: Redkar, Rajeev, et al.
Publicado: (2019)

Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability–High Colon Cancer
por: Hyung, Jaewon, et al.
Publicado: (2022)

The Effectiveness of Learning to Use HMD-Based VR Technologies on Nursing Students: Chemoport Insertion Surgery
por: Jung, Ae-Ri, et al.
Publicado: (2022)

Dexmedetomidine-ketamine versus Dexmedetomidine-midazolam-fentanyl for monitored anesthesia care during chemoport insertion: a Prospective Randomized Study
por: Chun, Eun Hee, et al.
Publicado: (2016)

The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer
por: Kim, Seung Tae, et al.
Publicado: (2018)

A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
por: Kim, Jwa Hoon, et al.
Publicado: (2020)

Aortic Regurgitation after Chemoport Catheter Insertion: Diagnostic Dilemma
por: Hanjoora, Vijay Mohan, et al.
Publicado: (2018)

Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer
por: Kim, Dalyong, et al.
Publicado: (2017)

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer
por: Kim, Dalyong, et al.
Publicado: (2017)

CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
por: Kang, Sora, et al.
Publicado: (2023)

Migration of chemoport catheter to the right ventricle: A catastrophic rare complication
por: Goyal, Neha, et al.
Publicado: (2022)

Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling
por: Kim, Eun Ho, et al.
Publicado: (2022)

Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer
por: Lee, Eunyoung, et al.
Publicado: (2016)

Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases
por: Jang, Ki Ung, et al.
Publicado: (2016)

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
por: Kim, Kyu-pyo, et al.
Publicado: (2017)

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
por: Kim, Yong Tae, et al.
Publicado: (2023)

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
por: Chon, Young Eun, et al.
Publicado: (2022)

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
por: LIM, SUNG HEE, et al.
Publicado: (2023)

Ascending Colon Cancer with Pathologically Confirmed Tumor Thrombosis of Superior Mesenteric Vein: A Case Report
por: Kim, Sung Eun, et al.
Publicado: (2019)

Association between human resources and risk of hospitalisation in end-stage renal disease outpatients receiving haemodialysis: a longitudinal cohort study using claim data during 2013–2014
por: Choi, Hoon-Hee, et al.
Publicado: (2016)

Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases
por: Shin, Dong-Won, et al.
Publicado: (2020)

The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy
por: Yeom, Seung-Seop, et al.
Publicado: (2020)

Fatal Subacute Stent Thrombosis Induced by Guidewire Fracture with Retained Filaments in the Coronary Artery
por: Kim, Tae-Jin, et al.
Publicado: (2013)

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
por: Cha, Yongjun, et al.
Publicado: (2017)

A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
por: Won, Sang Eun, et al.
Publicado: (2020)

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
por: Kim, Youjin, et al.
Publicado: (2019)

Steps involved and trouble-shooting during chemoport placement: How we do it?
por: Naik, Vibhavari, et al.
Publicado: (2022)

RNA editing in RHOQ promotes invasion potential in colorectal cancer
por: Han, Sae-Won, et al.
Publicado: (2014)

Simultaneous multiple coronary arteries thrombosis in patients with STEMI
por: Kim, Seunghwan, et al.
Publicado: (2018)

Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pii199tv1nah2tv4r2h8v9r1ct